Vaccines are provided free of charge at government facilities, and private facilities cannot charge more than Rs 250 per dose.
As India’s massive vaccination campaign expands, IT giant Infosys Ltd and consulting and outsourcing services provider Accenture Plc announced on Wednesday that they would cover COVID-19 vaccination costs for their employees in India.
India’s vaccination campaign ramped up on Monday, with people above the age of 60, and individuals 45 or older suffering from certain medical conditions, now eligible for shots.
Vaccines will continue to be free at government health facilities, although private facilities cannot charge more than Rs 250 per dose, according to the government.
In an emailed statement, Chief Operating Officer Pravin Rao said, “Infosys is looking at partnering with health care providers to vaccinate employees and their immediate families as eligible.”
Accenture would cover the costs of vaccination for workers and dependents who are registered and want to obtain it, according to the company.
So far, the federal government has purchased at fixed prices the two COVID-19 vaccines approved in India – AstraZeneca’s shot produced by the Serum Institute and local player Bharat Biotech’s COVAXIN – and distributed them free of charge.
As early as January, many Indian firms, including Mahindra Group, an auto-to-technology conglomerate, and consumer goods giant ITC Ltd, were considering purchasing COVID-19 vaccines for their employees.
Following in the footsteps of its peers Infosys and Accenture, India’s largest IT firm TCS is likely to cover COVID-19 vaccination costs for its employees.
“Since the beginning of the COVID-19 pandemic, through our robust associate well-being services, we have provided end-to-end treatment and care for all of our associates and their families around the world. This included COVID research and treatment, the establishment of free isolation centres and free test camps across India, and premier COVID treatment care in hospitals, among other initiatives,” a TCS spokesperson said in a statement in response to Moneycontrol’s questions.
“Through TCS Cares, our employee well-being initiative, we were able to provide emotional support to ensure holistic treatment. The spokesperson said, “We remain committed to the well-being and treatment of all of our associates and their families, and this will continue in the vaccine process as well.”
About 4.5 lakh people work for the organisation, with the majority of them working from home.